Shareholder Alert: Ademi LLP investigates whether Avantax, Inc. has obtained a Fair Price in its transaction with Cetera


MILWAUKEE, Sept. 11, 2023 /PRNewswire/ -- Ademi LLP is investigating Avantax (NASDAQ: AVTA) for possible breaches of fiduciary duty and other violations of law in its transaction with Cetera.

AdemiLogo (PRNewsfoto/Ademi LLP)

Click here to learn how to join the action https://www.ademilaw.com/case/avantax-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

In the transaction, Avantax stockholders are expected to receive only $26.00 in cash per share, without interest and subject to required withholding taxes, valuing Avantax at approximately $1.2 billion, inclusive of Avantax's net debt. The transaction agreement unreasonably limits competing transactions for Avantax by imposing a significant penalty if Avantax accepts a competing bid. Avantax insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Avantax's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Avantax common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/avantax-inc.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                                    
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-avantax-inc--has-obtained-a-fair-price-in-its-transaction-with-cetera-301923353.html

SOURCE Ademi LLP

Werbung

Avantax Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Avantax nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
15.05.18 Blucora Outperform Barrington Research
28.07.17 Blucora Outperform Barrington Research
05.05.17 Blucora Buy The Benchmark Company
05.05.17 Blucora Outperform Barrington Research
03.03.17 Blucora Hold Standpoint Research